Tryton Medical: Built for Bifurcation

Located in Durham, N.C., Tryton Medical, Inc. is a leading developer of novel stent systems for the treatment of bifurcation lesions. The company was founded in 2003 by Aaron V. Kaplan, M.D. (professor of medicine at Dartmouth Medical School/Dartmouth- Hitchcock Medical Center) and Dan Cole to develop stents for the definitive treatment of bifurcation lesions.
www.trytonmedical.com

Tryton Fact
Tryton Ticker
Tryton Infographic

TRI-ZONE TECHNOLOGY

The Tryton Side Branch Stent System uses proprietary Tri-ZONE™ technology to offer a dedicated strategy for treating bifurcation lesions. Tryton is the first and only coronary bifurcation stent  to receive CE Mark for Left Main Indication.